Gene · 115650
Papers2,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coexistent alterations of BAFF and B-cell phenotypes in complicated CVID course. | J Allergy Clin Immunol | 2026 | 42219089 | PubTator, text mining | PubMed |
| Causal association analysis between 731 immune cells and cystitis: A 2-sample, bidirectional Mendelian randomization study. | Medicine (Baltimore) | 2026 | 42216398 | PubTator, text mining | PubMed |
| Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. | Exp Hematol Oncol | 2026 | 42210349 | PubTator, text mining | PubMed |
| From Extracellular Vesicles-Related Genes to Angiogenesis: KRT7 as a Modulator of the VEGF/VEGFR signaling-dependent angiogenesis in Pancreatic Adenocarcinoma. | Int J Med Sci | 2026 | 42158830 | PubTator, text mining | PubMed |
| Exploring current evidence on bispecific CAR-T cell therapy for acute leukemias: a systematic review. | Front Oncol | 2026 | 42109662 | PubTator, text mining | PubMed |
| Evolving treatments for Sjögren disease: current approaches and emerging targets. | Intern Med J | 2026 | 42033155 | PubTator, text mining | PubMed |
| Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Study. | Psoriasis (Auckl) | 2026 | 42016305 | PubTator, text mining | PubMed |
| Immune cells and ischemic stroke: A bidirectional Mendelian randomization analysis. | Medicine (Baltimore) | 2026 | 41961720 | PubTator, text mining | PubMed |
| CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate. | J Clin Exp Hematop | 2026 | 41922226 | PubTator, text mining | PubMed |
| The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies. | Autoimmun Rev | 2026 | 41903743 | PubTator, text mining | PubMed |
| MSTN and TCF12 as Candidate Immunometabolic Signatures in Glioma-Associated Foam Cells: Insights from Integrated Multi-Omics Analysis. | Curr Issues Mol Biol | 2026 | 41899441 | PubTator, text mining | PubMed |
| The cGAS-STING pathway in cancer: friend or foe. | Cell Death Dis | 2026 | 41881950 | PubTator, text mining | PubMed |
| Two-Sample Bidirectional Mendelian Randomization Analysis of the Causal Relationship Between Immune Cell Phenotypes and Systemic Lupus Erythematosus. | Clin Cosmet Investig Dermatol | 2026 | 41878553 | PubTator, text mining | PubMed |
| [Pathophysiological aspects of primary Sjögren's disease : From epithelial activation to systemic autoimmunity]. | Z Rheumatol | 2026 | 41848778 | PubTator, text mining | PubMed |
| Longitudinal multi-omics profiling of spinal muscular atrophy. | Neurotherapeutics | 2026 | 41825231 | PubTator, text mining | PubMed |
| New Insights into the Role of NF-κB in Hepatitis B Virus Infection. | Int J Biol Sci | 2026 | 41800244 | PubTator, text mining | PubMed |
| Single-Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2026 | 41787696 | PubTator, text mining | PubMed |
| Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. | J Transl Autoimmun | 2026 | 41782636 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response. | Front Immunol | 2026 | 41766880 | PubTator, text mining | PubMed |
| Elucidating the Causal Relationships Between B Cells, Dendritic Cells, and Multiple Sclerosis Pathogenesis. | Brain Behav | 2026 | 41764039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/115650/papers?page=2